The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure or the cellular immune responses. The funders played no role in the design and conduct of the study; collection, management, analysis, and int...
Saved in:
Published in | The Lancet infectious diseases Vol. 25; no. 3; pp. e122 - e123 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Ltd
01.03.2025
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure or the cellular immune responses. The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. MSS served in an advisory role and received funds to conduct research from Ocugen. |
---|---|
AbstractList | The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure or the cellular immune responses. The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. MSS served in an advisory role and received funds to conduct research from Ocugen. |
Author | Harcourt, Jennifer Douek, Daniel C Godbole, Sucheta Paden, Clinton Moreno, Alberto Vander Velden, Jake Rouphael, Nadine Bechnak, Kareem Bowen, Nicole Dib, Serena M Cook, Peter Jain, Shilpi Kim, Sungjin Radi, Christelle Tamin, Azaibi Ellis, Madison L Kalash, Suha Suthar, Mehul S Manning, Kelly E Laboune, Farida Henry, Amy R Pinsky, Benjamin A Paredes, Isabel Hicks, Heather Sahoo, Malaya K Gardner, Meredith |
Author_xml | – sequence: 1 givenname: Mehul S surname: Suthar fullname: Suthar, Mehul S email: msuthar@emory.edu organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA – sequence: 2 givenname: Kelly E surname: Manning fullname: Manning, Kelly E organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA – sequence: 3 givenname: Madison L surname: Ellis fullname: Ellis, Madison L organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA – sequence: 4 givenname: Shilpi surname: Jain fullname: Jain, Shilpi organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA – sequence: 5 givenname: Kareem surname: Bechnak fullname: Bechnak, Kareem organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA – sequence: 6 givenname: Jake surname: Vander Velden fullname: Vander Velden, Jake organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA – sequence: 7 givenname: Farida surname: Laboune fullname: Laboune, Farida organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA – sequence: 8 givenname: Amy R surname: Henry fullname: Henry, Amy R organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA – sequence: 9 givenname: Sucheta surname: Godbole fullname: Godbole, Sucheta organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA – sequence: 10 givenname: Sungjin surname: Kim fullname: Kim, Sungjin organization: Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30329, USA – sequence: 11 givenname: Malaya K surname: Sahoo fullname: Sahoo, Malaya K organization: Stanford University School of Medicine, Stanford, CA, USA – sequence: 12 givenname: Isabel surname: Paredes fullname: Paredes, Isabel organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA – sequence: 13 givenname: Serena M surname: Dib fullname: Dib, Serena M organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA – sequence: 14 givenname: Suha surname: Kalash fullname: Kalash, Suha organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA – sequence: 15 givenname: Christelle surname: Radi fullname: Radi, Christelle organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA – sequence: 16 givenname: Heather surname: Hicks fullname: Hicks, Heather organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA – sequence: 17 givenname: Azaibi surname: Tamin fullname: Tamin, Azaibi organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA – sequence: 18 givenname: Meredith surname: Gardner fullname: Gardner, Meredith organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA – sequence: 19 givenname: Nicole surname: Bowen fullname: Bowen, Nicole organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA – sequence: 20 givenname: Peter surname: Cook fullname: Cook, Peter organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA – sequence: 21 givenname: Clinton surname: Paden fullname: Paden, Clinton organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA – sequence: 22 givenname: Jennifer surname: Harcourt fullname: Harcourt, Jennifer organization: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, USA – sequence: 23 givenname: Benjamin A surname: Pinsky fullname: Pinsky, Benjamin A organization: Stanford University School of Medicine, Stanford, CA, USA – sequence: 24 givenname: Daniel C surname: Douek fullname: Douek, Daniel C organization: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA – sequence: 25 givenname: Nadine surname: Rouphael fullname: Rouphael, Nadine organization: Hope Clinic of Emory Vaccine Center, Emory University, Decatur, GA, USA – sequence: 26 givenname: Alberto surname: Moreno fullname: Moreno, Alberto email: camoren@emory.edu organization: Emory Vaccine Center, Emory University, Atlanta, GA, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39900094$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUtLAzEUhYMovn-CMuBGF6N5TpqFiNQnCgo-cBfSzK1Gp5maZAr998ZWXbjRbBLCd869nLOGFn3rAaEtgvcJJtXBHeGSlQwrtUvFHs5HltUCWs3fvORcyMXZe46soLUYXzEmkmC-jFaYUlmg-Cp6un-B4up2n5amNuMEddG_ebw8KYkqJsZa56Fwo3FoJxALD10KpnHR-efC2OQmLk0L82ycj6lI2ejptJ9lwRmfNtDS0DQRNr_udfRwdnrfvyivb84v-8fXpWVKpJLnIQKAwoCxykjGCSc1ZpwPpOBGCMqGUilqFVWWCMCs16M9ZpkQwK3hhK2j3blvXvK9g5j0yEULTWM8tF3UjFSMUtrjNKM7v9DXtgs-b5cpSSqJKVaZ2v6iusEIaj0ObmTCVH9nlgExB2xoYwww_EEI1p_d6Fk3-jN4TYWedaOrrDua6yDHMXEQdLQOvIXaBbBJ16370-Hwl4NtnHfWNG8w_Yf-A1_IpLc |
Cites_doi | 10.1016/S1473-3099(24)00738-2 10.1016/j.celrep.2024.114520 10.15585/mmwr.mm7337e2 |
ContentType | Journal Article |
Copyright | 2025 Elsevier Ltd 2025. Elsevier Ltd |
Copyright_xml | – notice: 2025 Elsevier Ltd – notice: 2025. Elsevier Ltd |
DBID | AAYXX CITATION NPM 0TZ 3V. 7QL 7RV 7U9 7X7 7XB 88E 8AO 8C1 8C2 8FI 8FJ 8FK ABUWG AEUYN AFKRA BENPR C1K CCPQU FYUFA GHDGH H94 K9. KB0 M0S M1P M7N NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1016/S1473-3099(25)00007-6 |
DatabaseName | CrossRef PubMed Pharma and Biotech Premium PRO ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (ProQuest) Lancet Titles Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Pharma and Biotech Premium PRO ProQuest One Academic Middle East (New) Lancet Titles ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Pharma and Biotech Premium PRO |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1474-4457 |
EndPage | e123 |
ExternalDocumentID | 39900094 10_1016_S1473_3099_25_00007_6 S1473309925000076 |
Genre | Letter Correspondence |
GroupedDBID | --- --K --M -RU ..I .1- .FO 0R~ 123 1B1 1P~ 1~5 29L 4.4 457 4G. 53G 5VS 6PF 7-5 71M 7RV 7X7 88E 8AO 8C1 8C2 8FI 8FJ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AAQXK AARKO AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABJNI ABMAC ABMZM ABUWG ABWVN ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BENPR BKEYQ BKOJK BNPGV BPHCQ BVXVI CCPQU CJTIS CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-Q GBLVA HF~ HMCUK HVGLF HZ~ IHE J1W KOM M1P M41 MO0 N9A NAPCQ O-L O9- OD- OO. OZT P-8 P-9 P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO R2- ROL RPZ SDG SEL SES SPCBC SSH SSI SSZ T5K TLN UKHRP UV1 WOW XBR Z5R AACTN AAYOK AFCTW ALIPV RIG AAYXX AGRNS CITATION NPM 0TZ 3V. 7QL 7U9 7XB 8FK C1K H94 K9. M7N PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c395t-4acc5ee2eb336a734141d0344b754a5523f7992c929c15e0388283c355e4ca413 |
IEDL.DBID | 7X7 |
ISSN | 1473-3099 1474-4457 |
IngestDate | Fri Jul 11 11:34:00 EDT 2025 Wed Aug 13 08:02:43 EDT 2025 Mon Jul 21 05:55:39 EDT 2025 Tue Jul 01 05:23:42 EDT 2025 Sat Mar 29 16:12:29 EDT 2025 Tue Aug 26 16:38:55 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c395t-4acc5ee2eb336a734141d0344b754a5523f7992c929c15e0388283c355e4ca413 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14 content type line 23 |
PMID | 39900094 |
PQID | 3171670209 |
PQPubID | 44001 |
ParticipantIDs | proquest_miscellaneous_3163222842 proquest_journals_3171670209 pubmed_primary_39900094 crossref_primary_10_1016_S1473_3099_25_00007_6 elsevier_sciencedirect_doi_10_1016_S1473_3099_25_00007_6 elsevier_clinicalkey_doi_10_1016_S1473_3099_25_00007_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2025 2025-03-00 2025-Mar 20250301 |
PublicationDateYYYYMMDD | 2025-03-01 |
PublicationDate_xml | – month: 03 year: 2025 text: March 2025 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | The Lancet infectious diseases |
PublicationTitleAlternate | Lancet Infect Dis |
PublicationYear | 2025 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Li, Faraone, Hsu (bib2) 2024; 43 Zhang, Dopfer-Jablonka, Cossmann (bib1) 2024; 27 Panagiotakopoulos, Moulia, Godfrey (bib3) 2024; 73 Edara, Manning, Ellis (bib4) 2022; 3 Liu, Yu, Jian (bib5) 2024; 25 Zhang (10.1016/S1473-3099(25)00007-6_bib1) 2024; 27 Liu (10.1016/S1473-3099(25)00007-6_bib5) 2024; 25 Edara (10.1016/S1473-3099(25)00007-6_bib4) 2022; 3 Li (10.1016/S1473-3099(25)00007-6_bib2) 2024; 43 Panagiotakopoulos (10.1016/S1473-3099(25)00007-6_bib3) 2024; 73 |
References_xml | – volume: 73 start-page: 819 year: 2024 end-page: 824 ident: bib3 article-title: Use of COVID-19 vaccines for persons aged ≥6 months: recommendations of the advisory committee on immunization practices - United States, 2024–2025 publication-title: MMWR Morb Mortal Wkly Rep – volume: 43 year: 2024 ident: bib2 article-title: Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants publication-title: Cell Rep – volume: 27 year: 2024 ident: bib1 article-title: Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion publication-title: iScience – volume: 3 year: 2022 ident: bib4 article-title: mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant publication-title: Cell Rep Med – volume: 25 start-page: e6 year: 2024 end-page: e7 ident: bib5 article-title: Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations publication-title: Lancet Infect Dis – volume: 25 start-page: e6 year: 2024 ident: 10.1016/S1473-3099(25)00007-6_bib5 article-title: Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(24)00738-2 – volume: 3 year: 2022 ident: 10.1016/S1473-3099(25)00007-6_bib4 article-title: mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant publication-title: Cell Rep Med – volume: 43 year: 2024 ident: 10.1016/S1473-3099(25)00007-6_bib2 article-title: Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants publication-title: Cell Rep doi: 10.1016/j.celrep.2024.114520 – volume: 27 year: 2024 ident: 10.1016/S1473-3099(25)00007-6_bib1 article-title: Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion publication-title: iScience – volume: 73 start-page: 819 year: 2024 ident: 10.1016/S1473-3099(25)00007-6_bib3 article-title: Use of COVID-19 vaccines for persons aged ≥6 months: recommendations of the advisory committee on immunization practices - United States, 2024–2025 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7337e2 |
SSID | ssj0017104 |
Score | 2.4720945 |
Snippet | The limitations of this study include the small cohort size, age group, examination of a single timepoint, and unknown effect of previous SARS-CoV-2 exposure... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e122 |
SubjectTerms | Antibodies COVID-19 COVID-19 vaccines FDA approval Health sciences Immune response Immune response (cell-mediated) Immunization Infectious diseases Mutation Severe acute respiratory syndrome coronavirus 2 |
Title | The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1473309925000076 https://dx.doi.org/10.1016/S1473-3099(25)00007-6 https://www.ncbi.nlm.nih.gov/pubmed/39900094 https://www.proquest.com/docview/3171670209 https://www.proquest.com/docview/3163222842 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LbxQxDLZKKyEkhGh5LZQqSD3AIe1OJslsTgi2W7VFfQgomluUySSol9mF3eX3Y2cePRV6mcNMHGkcJ_5sxzbAvnCqjnrsuTOh5lIWkVcqVjyPaBEZj4hCU4Lz-YU-uZZnpSo7h9uyu1bZn4npoK7nnnzkhznVdSkQ3JiPi1-cukZRdLVrofEAtqh0GUl1UQ4GF1Kk9oGZLHKeIxS6zeA5_Da8fC_UhxTQ4_ou3XQX9kw66PgpPOnAI_vUrvY2bIRmBx6ed-HxHXjcOuFYm1v0DEoUAvbl6kBwV7sFYks2vfxxesQzw_44TzTsJjkVwpI1YZ2cHuQ7YJTtQE0lmPvpbhBAMoSJrJxNkQwFtlk9h-vj2ffpCe9aKXCfG7XiEidVIQg0nXPtClRdMqup2l9VKOkUWqOxMEZ4BEs-U4FKxCDu8AhGgvQOFd0L2GzmTXgFLMMBXoy9ikg6NoQ3qqhjLCaRyp6aERz0TLSLtmKGHa6SEdctcd0KZRPXrR6B7llt-3RQPMAsnun_I5wMhB1eaHHAfUh3-zW13aZd2lsRG8G74TNuN4qhuCbM1zRGU2xqIsUIXrayMPwlYr10U_P1vyd_A48ENRFOF9l2YXP1ex3eIrJZVXtJfPE5mWZ7sPV5dnH19S8HLu-E |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIQESQjA-VhhgJJDgwVvj2E7zgBDqNrV0HUhsqG_GcWy0l7SjLYh_ir-RO-djTwNe9prkouR8vvv5PgFeCqvKoPuO29yXXMos8EKFgqcBT0S5Q0ShqcB5eqxHp_LDTM024HdbC0Npla1OjIq6nDvyke-l1NclQ3CTv1ucc5oaRdHVdoRGLRYT_-snHtmWb8f7uL6vhDg8OBmOeDNVgLs0VysurXPKe4GnyFTbDLW4TEpqfFdkSlqFB7OQ5blwiBtcojx1S0ET7NAue-ks6nx87zW4LlPcmlSZPuxSSvAL47jCRGYpTxF6XVQM7X3uLr4W6k0MIHJ9mS28DOtGm3d4F-40YJW9r6XrHmz4agtuTJtw_Bbcrp1-rK5lug8zFDo2-bQruC3tArEsG378Mt7nSc5-ID-Qhp1FJ4Zfssqvo5OFfBWMqitoiAWz3-wZAlaGsJTNDoZIhhukWj2A0yth8kPYrOaV3waW4ANO9J0KSNrPCd8UQYeQDQK1Wc17sNsy0SzqDh2mS10jrhviuhHKRK4b3QPdstq05aeoMA3akH8RDjrCBp_UuON_SHfaNTWNkliaC5HuwYvuNm5vitnYys_X9IymWNhAih48qmWh-0vEljEz9PHfX_4cbo5OpkfmaHw8eQK3BA0wjkl0O7C5-r72TxFVrYpnUZQZfL3qvfMHyrEnuQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlVICEF5BVpYJJDgsE289q7tA6pQ0qghtFSCoty26_Uu6sUJJAHx1_rrOrN-9FTg0qvjseLxPL6dJ8BrYWTp1cByk7uSJ0nqeSF9wWOPJ6LcIqJQ1OB8dKwOT5OPMznbgIu2F4bKKlubGAx1ObcUI-_HNNclRXCT931TFnEyGu8vfnDaIEWZ1nadRi0iU_fnNx7flu8nI_zWb4QYH3wdHvJmwwC3cS5XPDHWSucEnihjZVK06ElU0hC8IpWJkXhI82meC4sYwkbS0eQUdMcWfbRLrEH7j8-9BbfTOM1Ix7JhV16C_zasLoySNOYxwrCr7qH-l-7iWyHfhWQiV9f5xetwb_B_4_twrwGu7EMtaQ9gw1XbsHXUpOa34W4dAGR1X9NDmKEAsunJnuCmNAvEtWz4-dtkxKOc_UJ-IA07DwENt2SVW4eAC8UtGHVa0EILZr6bcwSvDCEqmx0MkQyVpVo9gtMbYfJj2KzmlXsKLMIbrBhY6ZF0kBPWKbzyPs08jVzNe7DXMlEv6mkduitjI65r4roWUgeua9UD1bJat62oaDw1-pN_EWYdYYNVagzyP6Q77TfVjcFY6ivx7sGr7mdUdcrfmMrN13SPorxYlogePKlloXtLxJmhSvTZ3x_-ErZQa_SnyfH0OdwRtMs41NPtwObq59rtIsBaFS-CJDM4u2nVuQQdyivv |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+KP.2-adapted+COVID-19+vaccine+improves+neutralising+activity+against+the+XEC+variant&rft.jtitle=The+Lancet+infectious+diseases&rft.au=Suthar%2C+Mehul+S&rft.au=Manning%2C+Kelly+E&rft.au=Ellis%2C+Madison+L&rft.au=Jain%2C+Shilpi&rft.date=2025-03-01&rft.eissn=1474-4457&rft.volume=25&rft.issue=3&rft.spage=e122&rft_id=info:doi/10.1016%2FS1473-3099%2825%2900007-6&rft_id=info%3Apmid%2F39900094&rft.externalDocID=39900094 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-3099&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-3099&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-3099&client=summon |